This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Michal Preminger, Ph.D., MBA
Head, Johnson & Johnson Innovation East North America at J&J


In her role as Head, J&J Innovation, North America, Michal, together with her team, is responsible for building, advancing, and managing the J&J External R&D portfolio of co-investments spanning across pharmaceutical, consumer health and medical devices. Prior to joining J&J, Michal headed the Harvard Medical Site of the Harvard Office of Technology Development. Previously, she held a number of business and R&D leadership positions, Board and SAB membership in biotech and tech companies, as well as not for profit organizations. She holds a Ph.D. from the Weizmann Institute of Science, an MBA from INSEAD, Fontainebleau, France, and a BA in Medicine from Hadassah Medical School, Hebrew University, Jerusalem.

Agenda Sessions

  • Panel: Investment view on Innovation in Cell & Gene Therapy